Manufacturing Systems, Single-Use

Nov 02, 2006
BioPharm International
Biopharmaceutical processes typically require a significant investment in equipment—often a substantial obstacle for start-up companies. The risk of drug development failure is often high, further limiting access to the required capital. Flexibility and lower capital outlays are required not only by start-up companies, but also by research organizations with multiple product lines and by companies requiring quick capacity increases. Disposable technologies offer the highest potential for these companies to meet their business requirements. With lower capital requirements and increased flexibility, disposables are an important part of these companies' risk management strategy.
Nov 01, 2006
BioPharm International
The number of biotechnology-based human therapeutic products in the late-stage pipeline, and the average cost to commercialize a biotech product, have steadily increased. This has required biotech companies to use economic analysis as a tool during process development and for making decisions about process design. Process development efforts now aim to create processes that are economical, as well as optimal and robust.
Jul 01, 2006
BioPharm International
By BioPharm International Editors
Disposables require less space than conventional equipment, and they can be assembled offsite into complete process trains.
Jun 01, 2006
BioPharm International
By BioPharm International Editors
Disposables can be used for media preparation, clarification, filling in downstream processes . . .
Dec 01, 2005
BioPharm International
By BioPharm International Editors
The cell density achieved in a CELLine bioreactor is typically 1 to 2 orders of magnitude higher than in a conventional culture vessel
Jul 01, 2005
BioPharm International
By BioPharm International Editors
Disposable technology has been used effectively as a process solution for over 25 years and new uses and applications are constantly being developed. The key to all applications is the ability to pre-sterilize components and systems with gamma radiation and package them against contamination.
Jul 01, 2005
BioPharm International
By BioPharm International Editors
Cell-line and process development expertise, along with disposable systems, assist in implementing strategies for fast expression enhancements.
Feb 01, 2005
BioPharm International
By BioPharm International Editors
Disposable products and systems have come a long way since they first entered the small-lab market in the 1970s. Today they are available for practically every aspect of biopharmaceutical manufacturing. Disposable systems are used for filtration, clarification, purification, and separation applications used in the production of vaccines, monoclonal antibodies, and other therapies. As the use of disposable systems grows, the concept of a completely disposable manufacturing process is becoming a reality.
Mar 01, 2004
BioPharm International
By BioPharm International Editors
Using disposable components for bioprocessing can reduce costs and complexity and may play an increasing role in large-scale biopharmaceutical manufacturing.
Oct 01, 2003
BioPharm International
By BioPharm International Editors
The biotechnology and pharmaceutical industries have some overriding concerns, namely regulatory and compliance issues, insufficient manufacturing capacity, and the economic challenges of producing niche drugs and therapies.
native1_300x100
lorem ipsum